Title
Peri-implant bone changes after using platelet-rich fibrin scaffold among Indians
Authors
Abhishek Balani*, Jaishree Tandon, Vinay Kharsan, Abhishek Karan, Heena Mazhar & Arunima Awasthy
Affiliation
Department of Oral and Maxillofacial Surgery, New Horizon Dental College and Research Institute, Sakri, Bilaspur, Chhattisgarh, India; *Corresponding author
Abhishek Balani - E-mail: abhibalani@gmail.com
Jaishree Tandon - E-mail: drjaishreetandon@gmail.com
Vinay Kharsan - E-mail: kharsan@rediffmail.com
Abhishek Karan - E-mail: abhishekkaran28@gmail.com
Heena Mazhar - E-mail: drheena101@gmail.com
Arunima Awasthy - E-mail: awasthi.arusha05@gmail.com
Article Type
Research Article
Date
Received June 1, 2024; Revised June 30, 2024; Accepted June 30, 2024, Published June 30, 2024
Abstract
Bone transplant with osteopromotive elements - such as herbal extracts - that promote the creation of new boneis of interest to dentists. Hence, we compared the bone loss around dental implants while placing platelet rich fibrin (PRF) scaffold alone and PRF scaffold with simvastatin (SIM) and PRF scaffold with Moringaoleifera (MO). There were thirty six patients total. A total of 36 implants, or twelve implants in all three categories, were the estimated sample size. Category 1: PRF scaffolds alone. Category 2: PRF scaffolds with SIM. Category 3: PRF scaffolds with MO. Alteration in the bones were measured with CBCT. It was observed that there was decreased loss of crestal bone in PRF+ SIM and PRF+MO as compared to PRF alone. The use of herbal osteopromotive agents like simvastitin and Moringaoleifera along with PRF scaffolds can be effective in reducing bone loss around dental implants.
Keywords
Dental implants, PRF scaffold, bone loss
Citation
Balani et al. Bioinformation 20(6): 600-604 (2024)
Edited by
Dr. Vini Mehta MDS
ISSN
0973-2063
Publisher
License
This is an Open Access article which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. This is distributed under the terms of the Creative Commons Attribution License.
